Toggle light / dark theme

A team of scientists from the University of Florida (UF) will use a $1.1 million grant to further their work on the use of artificial intelligence-or AI-powered medical research for predicting and diagnosing Parkinson’s disease while maintaining patient privacy.

This grant, from the National Institutes for Health (NIH), will allow the scientists to train artificial neural network models — computer systems modeled on the human brain and nervous system — and further develop AI technologies that can predict and diagnose Parkinson’s, according to a press release.

“The proposed research will remove a major roadblock that restricts medical data accessibility and hinders cloud-based operations of deep-learning artificial neural networks for biomedical research,” the investigators said.

Hierarchical phase-contrast tomography (HiP-CT) enables multiscale imaging of any region within an intact human organ down to cellular resolution. HiP-CT of five organ types revealed 3D morphological features in healthy and diseased tissue.

Today, we’re bringing you 10 EMERGING Technologies That Will Change The World. Better stick around for #1 to find out how Elon Musk may have plans to turn us all into human robots some day.
What’s up tech-heads and welcome to another episode of TechJoint! It really feels like we’re already living in the future every day. From 5G connectivity to self-driving cars being even more accessible, innovation is everywhere we look! It can sometimes be hard to imagine a world with even more innovation—a future world. What would it look like? What everyday problems would be solved? It’s a pretty good bet some technologies like artificial intelligence will be in our lives, playing important roles in the future of humankind. Other technologies may seem far fetched, unnecessary and frankly, unattainable. So buckle up, and let’s take a look at these 10 futuristic technologies that are going to change the world as we know it.

► Subscribe For More! https://goo.gl/FQqpG8

10 EMERGING technologies that will change the world.

10. 10 Voice Assistants.
9. Gene Splicing.
8. Mixed Reality.
7. Regenerative Medicine.
6. Fully Autonomous Vehicles.
5. Digital Wallets.
4. Artificial Intelligence.
3. Automation.
2. ‘Alive’ Building Materials.
1. Internet For Everyone.

► Disclaimer: This video description contains affiliate links. Meaning, if you click on one of the product links and make a purchase, we receive a small commission. This helps us keep making more videos. Thank you for your support!

For Copyright Issues, Please Contact [email protected]

The USA Government is secretly working on a real Anti Aging Pill which aims to extend peoples lifespan and improve their health. This new longevity research project even made Aubrey De Grey interested as he said in an interview. Although he’s working on other kinds of medication to make people live forever or at least to stop peoples aging.

Dr. David Sinclair’s main research interest is the epigenetics of aging, with a focus on epigenetic reprogramming of aging, NAD+ metabolism and sirtuins, and NAD+ precursors like NR and NMN. David Sinclair is also working on supplements that are supposed to slow down the aging process.

If you enjoyed this video, please consider rating this video and subscribing to our channel for more frequent uploads. Thank you! smile

TIMESTAMPS:
00:00 The first of its kind.
02:28 How this Pill is going to help.
04:48 Aubrey De Grey’s Opinion.
05:43 The Future of Longevity Biotechnology.
07:07 Last Words.

#aubreydegrey #longevity #aging

Germany’s COVID infections are now higher than ever. And the numbers keep growing.

That’s despite a relatively high vaccination rate. Almost 70 percent of Germans are fully vaccinated against the virus.

One of the main reasons are breakthrough infections — where the disease manages to bypass the jab.

The only consolation for the vaccinated is that severe illness is rare.

Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1

For more news go to: http://www.dw.com/en/
Follow DW on social media:
►Facebook: https://www.facebook.com/deutschewellenews/
►Twitter: https://twitter.com/dwnews.
►Instagram: https://www.instagram.com/dwnews.
Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/dwdeutsch.

Penn State researchers developed a prototype of a wearable, noninvasive glucose sensor, shown here on the arm. Credit: Jia Zhu, Penn State.

Penn State researchers develop first-of-its-kind wearable, noninvasive glucose monitoring device prototype.

Noninvasive glucose monitoring devices are not currently commercially available in the United States, so people with diabetes must collect blood samples or use sensors embedded under the skin to measure their blood sugar levels. Now, with a new wearable device created by Penn State researchers, less intrusive glucose monitoring could become the norm.

The LAVO bike from StudioMOM is the world’s first hydrogen bike, requiring no heavy batteries, particulates, or CO2 emissions for operation.

Nowadays, it seems bikes are the preferred mode of transportation in crowded cities. Traffic is no joke and public transportation has seen some major changes since the onset of the COVID-19 pandemic, so people are hitting the streets with shiny electric and portable bicycles. While bikes are generally more environmentally friendly than cars and trucks, they come with their own list of setbacks. Becoming the world’s first hydrogen bike, the LAVO bike from StudioMOM is a small solution to a big problem.

The dramatic rise of online learning during the COVID-19 pandemic has spotlit concerns about the role of technology in exam surveillance — and also in student cheating.

Some universities have reported more cheating during the pandemic, and such concerns are unfolding in a climate where technologies that allow for the automation of writing continue to improve.

Over the past two years, the ability of artificial intelligence to generate writing has leapt forward significantly, particularly with the development of what’s known as the language generator GPT-3. With this, companies such as Google, Microsoft, and NVIDIA can now produce “human-like” text.

EVP, patient advocacy & engagement, national patient advocate foundation.


Gwen Darien is Executive Vice President for Patient Advocacy and Engagement, at the National Patient Advocate Foundation (https://www.npaf.org/), an organization with a mission of bringing patient voices to health system delivery reform, developing and driving initiatives promoting equitable access to affordable quality health care, and prioritizing the patient voice in health system delivery reform to achieve person-centered care. She is also Executive Vice President at their sister organization, Patient Advocate Foundation (https://www.patientadvocate.org/), a national non-profit organization which provides case management services and financial aid to Americans with chronic, life threatening and debilitating illnesses.

Gwen is a longtime patient advocate who has played leadership roles in some of the country’s preeminent nonprofit organizations.

As a three-time cancer survivor herself, Gwen came into cancer advocacy expressly to change the experiences and outcomes for the patients who came after her and to change the public dialogue about cancer and other life-threatening illnesses.

In 2,005 Gwen started the first stand-alone advocacy entity in a professional cancer research organization, at the American Association for Cancer Research, launching CR magazine – a magazine for people with cancer and those who care for them. Later, she served as the executive director of the Samuel Waxman Cancer Research Foundation; director of The Pathways Project; and executive vice president of programs and services at the Cancer Support Community, where in each role, Gwen championed placing patients at the center of health system change, whether it was for research, public policy or direct services.

While serving as the chair or on the board of a wide range of program committees and workshop faculties, including the Community Engagement in Genomics Working Group of the National Human Genome Research Institute; a member of the US Pharmacopeia Board of Trustees; and as the past chair of PCORI’s Patient Engagement Advisory Panel, Gwen also continues to write about her experiences. Her most recent piece, Transformation: My Experience as a Patient and an Advocate in Three Chapters appeared in the National Academy of Medicine Perspectives (https://nam.edu/transformation-my-experience-as-a-patient-and-an-advocate-in-three-chapters/).

It came as Germany recorded more than 37,000 daily Covid cases on Friday, a record high for the second day running. Austria’s daily new coronavirus infections surged towards a record set a year ago, making a lockdown for the unvaccinated ever more likely. The most dramatic rises in fatalities have been in the past week in Russia, where more than 8,100 deaths were recorded, and Ukraine, with 3,800 deaths. Both countries have very low rates of vaccination and Ukraine announced a record 28,000 new cases in the past 24 hours. (5 Nov 2021)